Acne Benzoyl Peroxide Does An About Face
One of the problems with benzoyl peroxide topical acne
treatments is that they can be quite irritating, particularly to
sensitive skin. Those fans of benzoyl peroxide will thus be
pleased to learn that one skin care company that supplies
prescription acne and skin care products is releasing a
treatment with a delivery system that reduces benzoyl peroxide's
irritating effect.
Called NeoBenz Micro, this acne treatment will be available only
by prescription, which is one drawback. On the plus side, it
should mean that the acne sufferer is given the appropriate
strength to their particular needs. It is aimed at helping
people with mild to moderate acne, and comes in three strengths.
These are 3.5% benzoyl peroxide, 5.5% benzoyl peroxide, and 8.5%
benzoyl peroxide.
The difference in this treatment as compared to regular benzoyl
peroxide solutions, is that it is a time release product. The
method designed by SkinMedica, NeoBenz Micro's developer, uses
very small 'sponges', called microsponges. These hold the active
ingredient, in this case benzoyl peroxide, to be slowly released
throughout the day. It means that though acne is kept in contact
with benzoyl peroxide for the whole day, only small amounts of
it are released onto the skin. These amounts are enough to be
effective but far less irritating.
The side effects that this benzoyl peroxide acne treatment aims
at reducing are rashes, skin soreness, and irritation. Aside
from the unpleasant feeling these effects create, they
unfortunately also reduce the effectiveness of benzoyl peroxide
in clearing acne.
NeoBenz Micro is one example of a new trend in the
pharmaceutical industry. It aims at taking existing products and
developing new ways to package and deliver the active
ingredients, thus effectively modernizing many treatments. The
emphasis in the past had been more research oriented - finding
new and more powerful treatments rather than fine tuning
existing ones that were proven to work.
Other examples of this phenomena include converting treatments
into sprays, with the effect of increasing absorption and
convenience. MedPharm, a research contracting firm, is turning
one eczema treatment and two acne treatments into sprays. These
are still in the development stage, however.
References: 1.
in-pharmatechnologist.com/news/ng.asp?n=65831&m=1IPE215&c=qgtqmov
byiaxdub
2. outsourcing-pharma.com/news/ng.asp?id=64465